Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men aged 18 or older who have been diagnosed with prostate cancer (a specific type called adenocarcinoma, confirmed through a tissue test)
- People who have already had, or are scheduled to have, a prostate MRI and/or surgery to remove the prostate as part of their standard care
- People whose planned prostate cancer treatment and follow-up follow standard medical care guidelines
- People who are in good general health, as shown by their medical history and a health rating score of 0–2 on a standard scale used by doctors to measure how well a person can carry out daily activities (confirm with trial site)
- People who are willing and able to sign a consent form and follow all study requirements for the full duration of the trial
Who may not be able to join:
- People who have previously had certain prostate cancer treatments, including cryotherapy (freezing tissue), high-intensity focused ultrasound, or surgical removal of the prostate
- People who have a hip replacement (prosthesis)
- People for whom an MRI scan is not considered safe or suitable, based on the guidelines of the treating hospital or clinic
- People who have a medical condition, ongoing treatment, or abnormal test results that, in the treating doctor's opinion, could affect the trial results, prevent full participation, or make joining the trial not in the person's best interest
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tyler Seibert, MD, PhD, University of California, San Diego
Phone: 858-534-4811
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection of grade group ≥2 prostate cancer on histopathology
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.